CRISPR

Pharma’s use of synthetic biology could deliver radical innovation

https://pharmaphorum.com/r-d/pharma-synthetic-biology-radical-innovation/

Nobel winner Charpentier’s CRISPR Therapeutics gets $900m in reworked Vertex deal

https://pharmaphorum.com/news/nobel-winner-charpentiers-crispr-therapeutics-gets-900m-in-reworked-vertex-deal/

Casting aside CRISPR scissors and making a point with base editors

https://pharmaphorum.com/r-d/views-analysis-r-d/immune-cell-therapies-crispr-cas9-gene-editing/

Gene editing: beyond the hype

https://pharmaphorum.com/r-d/views-analysis-r-d/genome-editing-sangamo-beyond-the-hype/

2nd RNA Editing Summit 2020

https://pharmaphorum.com/events/2nd-rna-editing-summit-2020/

4th Annual Genome Editing USA Congress

https://pharmaphorum.com/partner-content/4th-annual-genome-editing-usa-congress/

GSK makes CRISPR play, funding Doudna lab in California

https://pharmaphorum.com/news/gsk-makes-crispr-play-funding-doudna-lab-in-california/

R&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointments

https://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/

Biotech Verve launches on mission to replace statins with CRISPR gene editing tech

https://pharmaphorum.com/news/biotech-verve-launches-on-mission-to-replace-statins-with-crispr-gene-editing-tech/

1 2 3 4

Close in 10 seconds

Pharmaphorum.com

Search